Published in Thorax on January 01, 1991
Proteinase 3-ANCA Vasculitis versus Myeloperoxidase-ANCA Vasculitis. J Am Soc Nephrol (2015) 0.87
N-Acetylcysteine attenuates tumor necrosis factor alpha levels in autoimmune inner ear disease patients. Immunol Res (2015) 0.75
Autoantibodies against neutrophils and monocytes: tool for diagnosis and marker of disease activity in Wegener's granulomatosis. Lancet (1985) 10.67
Anti-neutrophil cytoplasmic autoantibodies with specificity for myeloperoxidase in patients with systemic vasculitis and idiopathic necrotizing and crescentic glomerulonephritis. N Engl J Med (1988) 8.01
Systemic vasculitis with asthma and eosinophilia: a clinical approach to the Churg-Strauss syndrome. Medicine (Baltimore) (1984) 6.40
Wegener's granulomatosis autoantigen is a novel neutrophil serine proteinase. Blood (1989) 5.08
Anti-neutrophil cytoplasm antibodies in Wegener's granulomatosis recognize an elastinolytic enzyme. J Exp Med (1990) 3.37
Wegener's granulomatosis autoantibodies identify a novel diisopropylfluorophosphate-binding protein in the lysosomes of normal human neutrophils. J Clin Invest (1989) 3.34
Anti-neutrophil cytoplasmic autoantibody-associated glomerulonephritis and vasculitis. Am J Pathol (1989) 2.40
Autoantibodies against myeloid lysosomal enzymes in crescentic glomerulonephritis. Kidney Int (1990) 1.77
Antibodies to neutrophil cytoplasmic antigens in Wegener's granulomatosis and other conditions. Thorax (1989) 1.58
Significance of antibodies to cytoplasmic components of neutrophils. Thorax (1989) 1.07
Neutrophil cytoplasmic autoantibodies and Wegener's granulomatosis. Lancet (1989) 0.89
Autoantibodies to neutrophil cytoplasmic antigens in systemic vasculitis have the same target specificity. J Pathol (1989) 0.83
Nomenclature of systemic vasculitides. Proposal of an international consensus conference. Arthritis Rheum (1994) 14.16
Trimethoprim-sulfamethoxazole (co-trimoxazole) for the prevention of relapses of Wegener's granulomatosis. Dutch Co-Trimoxazole Wegener Study Group. N Engl J Med (1996) 4.18
Synergy between tumor suppressor APC and the beta-catenin-Tcf4 target Tcf1. Science (1999) 4.08
Measurement of increases in anti-double-stranded DNA antibody levels as a predictor of disease exacerbation in systemic lupus erythematosus. A long-term, prospective study. Arthritis Rheum (1990) 3.37
Wegener's granulomatosis autoantibodies identify a novel diisopropylfluorophosphate-binding protein in the lysosomes of normal human neutrophils. J Clin Invest (1989) 3.34
Fc gammaRIIIa-158V/F polymorphism influences the binding of IgG by natural killer cell Fc gammaRIIIa, independently of the Fc gammaRIIIa-48L/R/H phenotype. Blood (1997) 3.19
The PI-linked receptor FcRIII is released on stimulation of neutrophils. Nature (1988) 2.65
Association of chronic nasal carriage of Staphylococcus aureus and higher relapse rates in Wegener granulomatosis. Ann Intern Med (1994) 2.62
Are systemic corticosteroids useful in the management of orbital pseudotumors? Ophthalmology (1996) 2.44
Human neutrophils lose their surface Fc gamma RIII and acquire Annexin V binding sites during apoptosis in vitro. Blood (1995) 2.39
Association of autoantibodies to myeloperoxidase with different forms of vasculitis. Arthritis Rheum (1990) 2.24
Cloning and sequence analysis of beta-4 cDNA: an integrin subunit that contains a unique 118 kd cytoplasmic domain. EMBO J (1990) 2.23
Expression of connective tissue growth factor in human renal fibrosis. Kidney Int (1998) 2.19
Prevention of relapses in Wegener's granulomatosis by treatment based on antineutrophil cytoplasmic antibody titre. Lancet (1990) 2.12
Idiopathic thrombocytopenic purpura in pregnancy: a randomized trial on the effect of antenatal low dose corticosteroids on neonatal platelet count. Br J Obstet Gynaecol (1990) 2.00
[Sjögren's disease]. Ned Tijdschr Geneeskd (1994) 2.00
Proposal for a unified CCN nomenclature. Mol Pathol (2003) 1.98
Focal segmental glomerulosclerosis in a patient homozygous for a CD2AP mutation. Kidney Int (2007) 1.93
The effect of two different dosages of intravenous immunoglobulin on the incidence of recurrent infections in patients with primary hypogammaglobulinemia. A randomized, double-blind, multicenter crossover trial. Ann Intern Med (2001) 1.89
Activation of granulocytes by anti-neutrophil cytoplasmic antibodies (ANCA): a Fc gamma RII-dependent process. Clin Exp Immunol (1994) 1.85
A simple immunofluorescence test for the detection of platelet antibodies. Br J Haematol (1978) 1.85
Antiproteinase 3- and antimyeloperoxidase-associated vasculitis. Kidney Int (2000) 1.81
Skewed distribution of IgG Fc receptor IIa (CD32) polymorphism is associated with renal disease in systemic lupus erythematosus patients. Arthritis Rheum (1995) 1.80
Autoantibodies against myeloid lysosomal enzymes in crescentic glomerulonephritis. Kidney Int (1990) 1.77
Prediction of relapses in Wegener's granulomatosis by measurement of antineutrophil cytoplasmic antibody levels: a prospective study. Arthritis Rheum (2000) 1.74
Primary pulmonary hypertension in a patient with systemic lupus erythematosus: partial improvement with cyclophosphamide. J Rheumatol (1993) 1.71
Predominance of IgG1 and IgG4 subclasses of anti-neutrophil cytoplasmic autoantibodies (ANCA) in patients with Wegener's granulomatosis and clinically related disorders. Clin Exp Immunol (1991) 1.69
Vasculitis and antineutrophil cytoplasmic autoantibodies associated with propylthiouracil therapy. Lancet (1993) 1.67
Neutrophil activation in vitro and in vivo in Wegener's granulomatosis. Kidney Int (1994) 1.66
Antimyeloperoxidase-associated proliferative glomerulonephritis: an animal model. J Exp Med (1993) 1.63
The 40-kDa Fc gamma receptor (FcRII) on human neutrophils is essential for the IgG-induced respiratory burst and IgG-induced phagocytosis. J Immunol (1989) 1.63
Differential B- and T-cell activation in Wegener's granulomatosis. J Allergy Clin Immunol (1999) 1.62
A simple and sensitive method for determining plasma cell isotype and monoclonality in bone marrow using flowcytometry. Br J Haematol (1995) 1.60
Maternal genomic neutrophil FcRIII deficiency leading to neonatal isoimmune neutropenia. Blood (1990) 1.59
What is orbital pseudotumor? Surv Ophthalmol (1996) 1.58
Morphological changes of the spiral arteries in the placental bed in relation to pre-eclampsia and fetal growth retardation. Br J Obstet Gynaecol (1981) 1.56
Neutrophil Fc gamma RIIIb deficiency, nature, and clinical consequences: a study of 21 individuals from 14 families. Blood (1995) 1.55
The glomerular mesangium: uptake and transport of intravenously injected colloidal carbon in rats. Kidney Int (1976) 1.54
Monoclonal antibodies against myeloperoxidase are valuable immunological reagents for the diagnosis of acute myeloid leukaemia. Br J Haematol (1990) 1.53
Platelet satellitism is Fc gamma RIII (CD16) receptor-mediated. Am J Clin Pathol (1995) 1.50
Megakaryoblastic differentiation of proerythroblastic K562 cell-line cells. Leuk Res (1984) 1.45
Propionicacidemia, a new inborn error of metabolism. Pediatr Res (1968) 1.43
Scl-86, a marker antigen for diffuse scleroderma. J Clin Invest (1985) 1.43
Co-trimoxazole and Wegener's granulomatosis: more than a coincidence? Nephrol Dial Transplant (1997) 1.43
Typing of fetal platelet alloantigens when platelets are not available. Lancet (1990) 1.41
Prevalence and characterization of neutrophil cytoplasmic antibodies in autoimmune liver diseases. Hepatology (1993) 1.41
Isoimmune neonatal neutropenia caused by Fc gamma RIIIb antibodies in a Spanish child. Transfusion (1995) 1.41
In-vitro differentiation of cells of patients with acute undifferentiated leukaemia. Br J Haematol (1989) 1.41
Inflammation in autoimmunity: receptors for IgG revisited. Trends Immunol (2001) 1.41
G-CSF-induced decrease of the anti-granulocyte autoantibody levels in a patient with autoimmune granulocytopenia. Ann Hematol (1997) 1.40
[The role of perinuclear antineutrophil granulocytes cytoplasmic antibodies in the diagnosis of vasculitis and chronic inflammatory diseases]. Ned Tijdschr Geneeskd (1996) 1.40
Antinuclear antibodies in patients with Raynaud's phenomenon: clinical significance of anticentromere antibodies. Ann Rheum Dis (1982) 1.39
The VS and V blood group polymorphisms in Africans: a serologic and molecular analysis. Transfusion (1998) 1.39
Accelerated atherosclerosis in patients with Wegener's granulomatosis. Ann Rheum Dis (2004) 1.38
[Clinical thinking and decision-making in practice. A patient with arthritis, skin lesions and a perforated nasal septum]. Ned Tijdschr Geneeskd (1999) 1.38
The use of rhG-CSF in chronic autoimmune neutropenia: reversal of autoimmune phenomena, a case history. Br J Haematol (1996) 1.38
Leukocyte activation in sepsis; correlations with disease state and mortality. Intensive Care Med (2000) 1.38
A case of severe neonatal thrombocytopenia with schizencephaly associated with anti-HPA-1b and anti-HPA-2a. Br J Haematol (1994) 1.38
Autoantibodies to myeloperoxidase aggravate mild anti-glomerular-basement-membrane-mediated glomerular injury in the rat. Am J Pathol (1996) 1.37
Phosphatidylinositol-linked FcRIII mediates exocytosis of neutrophil granule proteins, but does not mediate initiation of the respiratory burst. J Immunol (1990) 1.37
Molecular background of VS and weak C expression in blacks. Transfusion (1997) 1.35
Increased frequency of B8/DR3 in scleroderma and association of the haplotype with impaired cellular immune response. Clin Exp Immunol (1981) 1.34
Cutaneous reactions to captopril. Predictive value of skin tests. Clin Allergy (1984) 1.34
Autoimmune thrombocytopenia: detection of platelet autoantibodies with the suspension immunofluorescence test. Br J Haematol (1980) 1.33
Individualised low-dose alglucerase therapy for type 1 Gaucher's disease. Lancet (1995) 1.32
The detection of granulocyte alloantibodies with an indirect immunofluorescence test. Br J Haematol (1977) 1.32
Monocyte activation in patients with Wegener's granulomatosis. Ann Rheum Dis (1999) 1.31
Changes in antibodies to C1q predict renal relapses in systemic lupus erythematosus. Am J Kidney Dis (1995) 1.29
Anti-neutrophil cytoplasmic autoantibodies in patients with symptomatic HIV infection. Clin Exp Immunol (1992) 1.29
Binding characteristics of dimeric IgG subclass complexes to human neutrophils. J Immunol (1989) 1.28
Systemic involvement and immunologic findings in patients presenting with Raynaud's phenomenon. Am J Med (1980) 1.28
Characterization of three new variant type cell lines derived from small cell carcinoma of the lung. Cancer Res (1985) 1.28
Soluble Fc gamma receptor III in human plasma originates from release by neutrophils. J Clin Invest (1990) 1.27
Monoclonal antibodies against human platelet glycoprotein IIIa. Br J Haematol (1983) 1.25
Glycoproteins V and Ib-IX form a noncovalent complex in the platelet membrane. J Biol Chem (1992) 1.24
Absence of cross-reactivity between captopril and enalapril. Lancet (1984) 1.24
Immune-complex glomerulopathy in patients treated with captopril. Lancet (1980) 1.23
B cell activity in systemic lupus erythematosus: depressed in vivo humoral immune response to a primary antigen (haemocyanin) and increased in vitro spontaneous immunoglobulin synthesis. Clin Exp Immunol (1983) 1.22
Biallelic neutrophil Na-antigen system is associated with a polymorphism on the phospho-inositol-linked Fc gamma receptor III (CD16). Blood (1990) 1.22
Interference of Wegener's granulomatosis autoantibodies with neutrophil Proteinase 3 activity. Clin Exp Immunol (1992) 1.22
Traditional and non-traditional risk factors contribute to the development of accelerated atherosclerosis in patients with systemic lupus erythematosus. Lupus (2006) 1.20
Granulocyte colony-stimulating factor administration to healthy volunteers: analysis of the immediate activating effects on circulating neutrophils. Blood (1994) 1.20
Immortalisation of human bone marrow endothelial cells: characterisation of new cell lines. Eur J Clin Invest (2000) 1.19
Interplay between VHL/HIF1alpha and Wnt/beta-catenin pathways during colorectal tumorigenesis. Oncogene (2006) 1.17
Neutrophil cytoplasmic antibodies (p-ANCA) in ulcerative colitis. J Clin Pathol (1994) 1.17
The localization of Hodgkin's disease in lymph nodes. A study with immunohistological, enzyme histochemical and rosetting techniques on frozen sections. Int J Cancer (1979) 1.16
Human vascular endothelial cells express a membrane protein complex immunochemically indistinguishable from the platelet VLA-2 (glycoprotein Ia-IIa) complex. Blood (1989) 1.16
Levels of soluble VCAM-1, soluble ICAM-1, and soluble E-selectin during disease exacerbations in patients with systemic lupus erythematosus (SLE); a long term prospective study. Clin Exp Immunol (1994) 1.15